Access to Healthcare Improves Health Outcomes for Vulnerable Youth in Foster Care

In an era when the importance of comprehensive healthcare is more apparent than ever, the attention has started shifting towards the most vulnerable communities. Amidst this, the role of foster care in providing essential care and improving health outcomes for young individuals who cannot cater to their own needs has taken center stage. According to Child Welfare, there are currently over 391,000 children in the foster care system, emphasizing the magnitude of this issue.

What role does foster care play in the overall healthcare landscape, and how does it contribute to enhanced health outcomes? This core question guides the conversation in the latest episode of the Highway to Health podcast series, hosted by David Kemp.

In this episode, Kemp welcomed Teresa Stivers, the CEO of Walden Family Services, to discuss the intricate dynamics of foster care and the ways it can lead to better healthcare access, experiences, and outcomes for young people. The topics covered in this enlightening conversation include:

  • The essential role of foster care in providing care and resources for young individuals who cannot cater to their own needs
  • The personal journey of Teresa Stivers, her health scare, and the subsequent lifestyle changes
  • A deep dive into Walden Family Services, its vision, mission, and the range of services provided

Teresa Stivers, an expert in the field of foster care services, has led Walden Family Services with a burning passion for the welfare of women and children. Her personal experiences with her own children’s health issues have shaped her approach to caring for foster children, particularly those with special healthcare needs.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…